Gentherm Reports Record 2012 Fourth Quarter, Year-End Revenues
On
President and CEO
"The acquisition of W.E.T. was a seminal event in the history of
Impact of One-time Events in 2012
During the 2012 fourth quarter and full year, basic and fully diluted earnings per share were
Second, during the fourth quarter of 2012,
Finally, the American Taxpayer Relief Act of 2012 ("the Act") was signed into law but not until
Adjusting for these impacts,
Fourth Quarter Financial Highlights
Revenues for the 2012 fourth quarter increased 13 percent to a record
New program launches for the Company's Climate Control Seat™ (CCS™) include the Ford Flex, Nissan Pathfinder, Infiniti JX, Hyundai i40 and Kia K9 Cadenza. Certain existing vehicle programs had higher revenue during the period as a result of
Partially offsetting higher product revenues during the 2012 fourth quarter was a decline related to the weakening of the Euro against the U.S. Dollar which negatively impacted the Company's Euro-denominated revenues. The Euro-denominated product revenue for the 2012 fourth quarter was €31.1 million and the average U.S. Dollar/Euro exchange rate for the quarter was 1.2969. If the average exchange rate for the 2012 fourth quarter had been equal to the average U.S. Dollar/Euro rate for the fourth quarter of 2011, which was 1.3490,
"While there was some softness in
Net income attributable to common shareholders for the 2012 fourth quarter was
Net income attributable to common shareholders for the fourth quarter of 2011 was
Gross margin as a percentage of revenue for the fourth quarter of 2012 decreased to 25.8 percent, down slightly from 25.9 percent for the fourth quarter of 2011. This decrease was primarily the result of the higher cost of sales reported from the one-time additional royalty expense totaling
Adjusted EBITDA for the fourth quarter of 2012 was
Historical
2012 Year-End Financial Highlights
For 2012, revenues increased to
Partially offsetting higher product revenues in 2012 is a decline related to the weakening of the Euro against the U.S. Dollar which negatively impacted the Company's Euro-denominated revenues. The Euro-denominated product revenue for 2012 was €126.6 million and the average U.S. Dollar/Euro exchange rate for the year was 1.2861. If the average exchange rate for 2012 had been equal to the average U.S. Dollar/Euro rate for all of 2011, which was 1.3921,
Net income attributable to common shareholders for 2012 was
Net income attributable to common shareholders in 2011 was
Gross margin as a percentage of revenue in 2012 was 25.6 percent compared with 25.7 percent in 2011. This decrease was primarily the result of the higher cost of sales reported from the one-time additional royalty expense totaling
Adjusted EBITDA in 2012 (which is described in the tables that follow) was
Interest Expense and Revaluation of Derivatives
Interest expense for the 2012 fourth quarter and full year was
For the 2012 fourth quarter and year, the Company recorded losses related to the revaluation of derivative financial instruments of
Research and Development, Selling, General and Administrative Expenses
Net research and development expenses were approximately the same during the 2012 fourth quarter results as compared to the 2011 fourth quarter. Net research and development expenses for the 2012 full year were up
As previously described, during the fourth quarter of 2012,
Selling, general and administrative (SG&A) expenses for the 2012 fourth quarter and year increased
The Company's balance sheet as of
Guidance
Barring unforeseen economic turbulence, including worsening of the European market or unfavorable fluctuations of the Euro exchange rate, 2013 revenue appears to be strong. Gentherm is expecting revenue for 2013 to increase 8 to 10 percent over 2012 revenues, which were
Conference Call
As previously announced,
Note Regarding Use of Non-GAAP Financial Measures
Certain of the information set forth herein, including Adjusted EBITDA and historical
About
Certain matters discussed in this release are forward-looking statements that involve risks and uncertainties, and actual results may be different. Important factors that could cause the Company's actual results to differ materially from its expectations in this release are risks that sales may not significantly increase, additional financing, if necessary, may not be available, new competitors may arise and adverse conditions in the automotive industry may negatively affect its results. The liquidity and trading price of its common stock may be negatively affected by these and other factors. Please also refer to
TABLES FOLLOW
|
GENTHERM INCORPORATED |
||||
|
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS |
||||
|
(In thousands, except per share data) |
||||
|
Three Months Ended |
Year Ended |
|||
|
December 31, |
December 31, |
|||
|
2012 |
2011 |
2012 |
2011 |
|
|
Product revenues |
$ 148,242 |
$ 131,016 |
$ 554,979 |
$ 369,588 |
|
Cost of sales |
109,942 |
97,115 |
413,052 |
274,621 |
|
Gross margin |
38,300 |
33,901 |
141,927 |
94,967 |
|
Operating costs and expenses: |
||||
|
Research and development |
10,860 |
10,738 |
43,189 |
30,665 |
|
Research and development reimbursements |
(476) |
(351) |
(2,239) |
(932) |
|
Net research and development expenses |
10,384 |
10,387 |
40,950 |
29,733 |
|
Acquisition transaction expenses |
– |
(64) |
– |
5,316 |
|
Selling, general and administrative |
18,947 |
16,018 |
64,919 |
42,110 |
|
Total operating costs and expenses |
29,331 |
26,341 |
105,869 |
77,159 |
|
Operating income |
8,969 |
7,560 |
36,058 |
17,808 |
|
Interest expense |
(1,054) |
(1,060) |
(4,136) |
(3,511) |
|
Debt retirement expense |
– |
(190) |
– |
(1,160) |
|
Revaluation of derivatives |
(1,236) |
(545) |
(2,292) |
(6,118) |
|
Foreign currency gain (loss) |
(156) |
5,795 |
2,201 |
9,207 |
|
Loss from equity investment |
146 |
(82) |
(243) |
|
|
Other income |
64 |
(638) |
923 |
(114) |
|
Earnings before income tax |
6,733 |
10,922 |
32,672 |
15,869 |
|
Income tax expense |
1,027 |
852 |
8,351 |
4,666 |
|
Net income |
5,706 |
10,070 |
24,321 |
11,203 |
|
Loss (gain) attributable to non-controlling interest |
(1,958) |
(1,720) |
(6,449) |
(1,545) |
|
Net income attributable to Gentherm, Inc |
3,748 |
8,350 |
17,872 |
9,658 |
|
Convertible preferred stock dividends |
(1,190) |
(2,490) |
(6,711) |
(8,228) |
|
Net income (loss) attributable to common shareholders |
$ 2,558 |
$ 5,860 |
$ 11,161 |
$ 1,430 |
|
Basic earnings (loss) per share |
$ 0.09 |
$ 0.25 |
$ 0.39 |
$ 0.06 |
|
Diluted earnings (loss) per share |
$ 0.09 |
$ 0.24 |
$ 0.39 |
$ 0.06 |
|
Weighted average number of shares – basic |
29,717 |
23,361 |
28,353 |
22,606 |
|
Weighted average number of shares – diluted |
30,082 |
23,986 |
28,862 |
23,455 |
FOURTH QUARTER RESULTS EXCLUDING W.E.T.
The following table presents select operations data for the period as reported, amounts for W.E.T. operations and amounts for
|
Three-month period ended December 31, 2012 |
|||||||
|
(In Thousands) |
|||||||
|
As Reported |
Less: W.E.T. |
Historical Gentherm |
|||||
|
Product revenues |
$ 148,242 |
$ 112,094 |
$ 36,148 |
||||
|
Cost of sales (1) |
109,942 |
82,109 |
27,833 |
||||
|
Gross margin |
38,300 |
29,985 |
8,315 |
||||
|
Gross margin percent |
25.8% |
26.7% |
23.0% |
||||
|
Operating expenses: |
|||||||
|
Net research and development expenses |
10,384 |
7,626 |
2,758 |
||||
|
Selling, general and administrative expenses (2) |
18,947 |
13,484 |
5,463 |
||||
|
Operating income |
8,969 |
8,875 |
94 |
||||
|
Earnings before income tax |
6,733 |
7,215 |
(482) |
||||
|
(1)Amount for Historical Gentherm includes one-time additional royalty expense totaling $1,611. (2)During the 2012 fourth quarter, historical Gentherm incurred approximately $260 in expenses related to the DPLTA and Sarbanes-Oxley compliance for W.E.T. within selling, general and administrative expenses. |
|||||||
|
Three-month period ended December 31, 2011 |
|||||||
|
(In Thousands) |
|||||||
|
As Reported |
Less: W.E.T. |
Historical Gentherm |
|||||
|
Product revenues |
$ 131,016 |
$ 96,948 |
$ 34,068 |
||||
|
Cost of sales |
97,115 |
72,332 |
24,783 |
||||
|
Gross margin |
33,901 |
24,616 |
9,285 |
||||
|
Gross margin percent |
25.9% |
25.4% |
27.3% |
||||
|
Operating expenses: |
|||||||
|
Net research and development expenses |
10,387 |
7,739 |
2,648 |
||||
|
Acquisition transaction expenses |
(64) |
(245) |
181 |
||||
|
Selling, general and administrative expenses |
16,018 |
11,835 |
4,183 |
||||
|
Operating income |
7,560 |
5,287 |
2,273 |
||||
|
Earnings before income tax |
10,922 |
9,403 |
1,519 |
||||
FULL YEAR RESULTS EXCLUDING W.E.T.
The following table presents select operations data for the period as reported, amounts for W.E.T. operations and amounts for
|
Twelve-month period ended December 31, 2012 |
|||||||
|
(In Thousands) |
|||||||
|
As Reported |
Less: W.E.T. |
Historical Gentherm |
|||||
|
Product revenues |
$ 554,979 |
$ 422,714 |
$ 132,265 |
||||
|
Cost of sales (1) |
413,052 |
316,471 |
96,581 |
||||
|
Gross margin |
141,927 |
106,243 |
35,684 |
||||
|
Gross margin percent |
25.6% |
25.1% |
27.0% |
||||
|
Operating expenses: |
|||||||
|
Net research and development expenses |
40,950 |
30,600 |
10,350 |
||||
|
Selling, general and administrative expenses (2) |
64,919 |
44,494 |
20,425 |
||||
|
Operating income |
36,058 |
31,149 |
4,909 |
||||
|
Earnings before income tax |
32,672 |
30,216 |
2,456 |
||||
|
(1)Amount for Historical Gentherm includes one-time additional royalty expense totaling $1,611. (2)During the period ending December 31, 2012, historical Gentherm incurred approximately $1,950 in expenses related to the |
|||||||
|
Twelve-month period ended December 31, 2011 |
|||||||
|
(In Thousands) |
|||||||
|
As Reported |
Less: W.E.T. |
Historical Gentherm |
|||||
|
Product revenues |
$ 369,588 |
$ 237,248 |
$ 132,340 |
||||
|
Cost of sales |
274,621 |
179,374 |
95,247 |
||||
|
Gross margin |
94,967 |
57,874 |
37,093 |
||||
|
Gross margin percent |
25.7% |
24.4% |
28.0% |
||||
|
Operating expenses: |
|||||||
|
Net research and development expenses |
29,773 |
18,793 |
10,980 |
||||
|
Acquisition transaction expenses |
5,316 |
468 |
4,848 |
||||
|
Selling, general and administrative expenses |
42,110 |
27,747 |
14,363 |
||||
|
Operating income |
17,808 |
10,866 |
6,942 |
||||
|
Earnings before income tax |
15,869 |
9,050 |
6,819 |
||||
|
GENTHERM INCORPORATED |
||||
|
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME |
||||
|
(Unaudited, in thousands) |
||||
|
Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||
|
2012 |
2011 |
2012 |
2011 |
|
|
Net income (loss) |
$ 5,706 |
$ 10,070 |
$ 24,321 |
$ 11,203 |
|
Add Back: |
||||
|
Income tax expense |
1,027 |
852 |
8,351 |
4,666 |
|
Interest expense (income) |
1,054 |
1,060 |
4,136 |
3,511 |
|
Depreciation and amortization |
7,660 |
7,482 |
29,595 |
22,385 |
|
Adjustments: |
||||
|
Acquisition transaction expense |
– |
(64) |
– |
5,316 |
|
Debt retirement expense |
– |
190 |
– |
1,160 |
|
Unrealized currency (gain) loss |
1,437 |
(5,611) |
3,350 |
(3,756) |
|
Unrealized revaluation of derivatives |
1,234 |
544 |
(248) |
4,685 |
|
Adjusted EBITDA |
$ 18,118 |
$ 14,523 |
$ 69,505 |
$ 49,170 |
Use of Non-GAAP Financial Measures
In evaluating its business,
The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP.
|
GENTHERM INCORPORATED |
||||||||
|
ACQUISITION TRANSACTION EXPENSES, W.E.T. PURCHASE ACCOUNTING IMPACTS AND OTHER EFFECTS |
||||||||
|
(In thousands, except per share data) |
||||||||
|
Three Months Ended December 31, |
Twelve Months Ended December 31, |
Future Periods (estimated) |
||||||
|
2012 |
2011 |
2012 |
2011 |
2013 |
2014 |
2015 |
Thereafter |
|
|
Transaction related current expenses |
||||||||
|
Acquisition transaction expenses |
$ – |
$ (64) |
$ – |
$ 5,326 |
$ – |
$ – |
$ – |
$ – |
|
Debt retirement expense |
– |
190 |
– |
1,160 |
– |
– |
– |
– |
|
– |
126 |
– |
6,476 |
– |
– |
– |
– |
|
|
Non-cash purchase accounting impacts |
||||||||
|
Customer relationships amortization |
$ 1,945 |
$ 2,090 |
$ 7,717 |
$ 5,222 |
$ 7,717 |
$ 7,922 |
$ 7,922 |
$ 40,861 |
|
Technology amortization |
816 |
876 |
3,236 |
2,190 |
3,236 |
3,322 |
3,322 |
6,253 |
|
Product development costs amortization |
526 |
440 |
2,087 |
1,002 |
2,136 |
2,193 |
1,242 |
50 |
|
Order backlog amortization |
– |
– |
– |
3,032 |
– |
– |
– |
– |
|
Inventory fair value adjustment |
– |
– |
– |
1,481 |
– |
– |
– |
– |
|
$ 3,287 |
$ 3,406 |
$ 13,040 |
$ 12,927 |
$ 13,089 |
$ 13,437 |
$ 12,486 |
$ 47,164 |
|
|
Tax effect |
(761) |
(835) |
(3,020) |
(4,001) |
(3,031) |
(3,112) |
(2,892) |
(10,923) |
|
Net income effect |
2,526 |
2,697 |
10,020 |
15,402 |
10,058 |
10,325 |
9,594 |
36,241 |
|
Non-controlling interest effect |
(608) |
(621) |
(2,413) |
(2,356) |
(101) |
(103) |
(96) |
(362) |
|
Net income available to shareholders effect |
$ 1,918 |
$ 2,076 |
$ 7,607 |
$ 13,046 |
$ 9,957 |
$ 10,222 |
$ 9,498 |
$ 35,878 |
|
Earnings (loss) per share - difference |
||||||||
|
Basic |
$ 0.06 |
$ 0.09 |
$ 0.27 |
$ 0.58 |
||||
|
Diluted |
$ 0.06 |
$ 0.09 |
$ 0.26 |
$ 0.56 |
||||
|
Series C Preferred Stock dividend |
$ 1,190 |
$ 2,490 |
$ 6,711 |
$ 8,228 |
$ 1,622 |
$ – |
$ – |
$ – |
|
Earnings (loss) per share - difference |
||||||||
|
Basic |
$ 0.04 |
$ 0.11 |
$ 0.24 |
$ 0.36 |
||||
|
Diluted |
$ 0.04 |
$ 0.10 |
$ 0.23 |
$ 0.35 |
||||
|
GENTHERM INCORPORATED |
||
|
CONSOLIDATED BALANCE SHEETS |
||
|
(In thousands, except share data) |
||
|
December 31, |
||
|
ASSETS |
2012 |
2011 |
|
Current Assets: |
||
|
Cash & cash equivalents |
$ 58,152 |
$ 23,839 |
|
Accounts receivable |
102,261 |
82,395 |
|
Inventory |
53,756 |
46,344 |
|
Derivative financial instruments |
160 |
2,675 |
|
Deferred income tax assets |
15,006 |
12,732 |
|
Prepaid expenses and other assets |
12,809 |
9,685 |
|
Total current assets |
242,144 |
177,670 |
|
Property and equipment, net |
55,010 |
44,794 |
|
Goodwill |
24,729 |
24,245 |
|
Other intangible assets |
95,870 |
103,806 |
|
Deferred financing costs |
1,880 |
2,441 |
|
Deferred income tax assets |
5,361 |
13,147 |
|
Derivative financial instruments |
4,141 |
— |
|
Other non-current assets |
10,062 |
8,774 |
|
Total assets |
$ 439,197 |
$ 374,877 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
||
|
Current Liabilities: |
||
|
Accounts payable |
$ 42,508 |
$ 42,533 |
|
Accrued liabilities |
54,157 |
46,293 |
|
Current maturities of long-term debt |
17,218 |
14,570 |
|
Derivative financial instruments |
3,326 |
5,101 |
|
Deferred tax liabilities |
— |
3,218 |
|
Total current liabilities |
117,209 |
111,715 |
|
Pension benefit obligation |
5,009 |
3,872 |
|
Other Liabilities |
4,540 |
1,862 |
|
Long-term debt, less current maturities |
39,734 |
61,677 |
|
Derivative financial instruments |
13,245 |
17,189 |
|
Deferred tax liabilities |
21,828 |
23,679 |
|
Total liabilities |
201,565 |
219,994 |
|
Commitments and contingencies |
||
|
Series C Convertible Preferred Stock.. |
22,469 |
50,098 |
|
Shareholders' equity: |
||
|
Common Stock: |
||
|
No par value; 55,000,000 shares authorized, 29,818,225 and 23,515,571 issued and outstanding at December 31, 2012 and 2011, respectively |
166,309 |
80,502 |
|
Paid-in capital |
23,778 |
23,387 |
|
Accumulated other comprehensive income |
(10,889) |
(14,754) |
|
Accumulated deficit |
(17,383) |
(28,544) |
|
Total Gentherm Incorporated shareholders' equity |
161,815 |
60,591 |
|
Non-controlling interest |
53,348 |
44,194 |
|
Total shareholders' equity |
215,163 |
104,785 |
|
Total liabilities and shareholders' equity |
$ 439,197 |
$ 374,877 |
|
GENTHERM INCORPORATED |
||
|
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS |
||
|
(In thousands) |
||
|
Year Ended December 31, |
||
|
2012 |
2011 |
|
|
Operating Activities: |
||
|
Net income |
$24,321 |
$ 11,203 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
||
|
Depreciation and amortization |
30,627 |
23,282 |
|
Deferred income tax expense (benefit) |
789 |
(599 ) |
|
Loss on revaluation of derivatives |
167 |
6,118 |
|
Debt extinguishment expenses |
— |
960 |
|
Stock compensation |
1,252 |
2,073 |
|
Loss on sale of property, plant & equipment |
555 |
35 |
|
Provision for doubtful accounts |
533 |
1,241 |
|
Defined benefit plan expense |
50 |
266 |
|
Excess tax benefit from equity awards |
171 |
(3,257 ) |
|
(Gain) Loss from equity investment |
82 |
243 |
|
Changes in operating assets and liabilities: |
||
|
Accounts receivable |
(18,367) |
(12,639 ) |
|
Inventory |
(5,847) |
(4,624 ) |
|
Prepaid expenses and other assets |
(3,228) |
1,937 |
|
Accounts payable |
1,788 |
4,722 |
|
Accrued liabilities |
4,314 |
3,266 |
|
Net cash provided by operating activities |
37,207 |
34,227 |
|
Investing Activities: |
||
|
Purchases of derivative financial instruments |
(7,787) |
— |
|
Sales and maturities of short-term investments |
— |
9,761 |
|
Investment in subsidiary, net of cash acquired |
— |
(113,432 ) |
|
Equity investment |
— |
(491 ) |
|
Loan to equity investment |
(590) |
(860 ) |
|
Cash invested in corporate owned life insurance |
(265) |
(266 ) |
|
Purchase of property and equipment |
(26,793) |
(10,673 ) |
|
Proceeds from the sale of property and equipment |
40 |
— |
|
Net cash provided by (used in) investing activities |
(35,395) |
(115,961 ) |
|
Financing Activities: |
||
|
Distribution paid to non-controlling interest |
(290) |
— |
|
Cash paid for financing costs |
(264) |
(4,493 ) |
|
Borrowing of Debt |
3,326 |
138,168 |
|
Repayments of Debt |
(22,953) |
(110,775 ) |
|
Proceeds from public offering of common stock |
75,532 |
— |
|
Proceeds from the sale of Series C Convertible Preferred Stock |
— |
61,403 |
|
Proceeds from the sale of embedded derivatives |
— |
2,610 |
|
Excess tax benefit from equity awards |
(171) |
3,257 |
|
Proceeds from sale of W.E.T. equity to non-controlling interest |
1,921 |
1,175 |
|
Redemption of Series C Preferred Stock |
(25,740) |
(7,780 ) |
|
Series C Preferred Stock Holders dividend |
— |
(1,362 ) |
|
Proceeds from the exercise of Common Stock options |
774 |
3,345 |
|
Proceeds from sale of common stock, net of cash expenses |
— |
— |
|
Net cash provided by (used in) financing activities |
32,135 |
85,548 |
|
Foreign currency effect on cash and cash equivalents |
366 |
(6,559 ) |
|
Net (decrease) increase in cash and cash equivalents |
34,313 |
(2,745 ) |
|
Cash and cash equivalents at beginning of period |
23,839 |
26,584 |
|
Cash and cash equivalents at end of period |
$ 58,152 |
$ 23,839 |
|
Supplemental disclosure of cash flow information: |
||
|
Cash paid for interest |
$ 3,545 |
$ 3,963 |
|
Cash paid for taxes |
$ 8,445 |
$ 5,322 |
|
Supplemental disclosure of non-cash transactions: |
||
|
Issuance of Common Stock for Series C Preferred Stock redemption |
$ 7,780 |
$ 7,780 |
|
Issuance of Common Stock for Series C Preferred Stock dividend |
$ 1,031 |
$ 2,242 |
|
Common stock issued to directors and employees |
$ 429 |
$ 669 |
|
Contact: |
Allen & Caron Inc |
|
Jill Bertotti (investors) |
|
|
Len Hall (media) |
|
|
(949) 474-4300 |
SOURCE